ClinConnect ClinConnect Logo
Search / Trial NCT01176422

Telomere and Telomerase

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Aug 4, 2010

Trial Information

Current as of August 02, 2025

Withdrawn

Keywords

Aml Mds

ClinConnect Summary

A telomere is a region of repetitive DNA at the end of chromosomes, which protects the end of the chromosome from destruction. Telomeres can be viewed as the tips on the ends of shoelaces that keep them from unraveling. Telomeres compensate for incomplete semi-conservative DNA replication at chromosomal ends. In absence of a reparative process, DNA sequences would be lost in every replicative phase until they reached a critical level, at which point cell division would stop.

Loss of telomeres leads to chromosome end-to-end fusion, chromosome re-arrangements, and genome instability.

Telome...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of advanced Myelodysplastic Syndrome (MDS) or acute myeloid leukemia
  • must be 18 years of age
  • must be able to give written informed consent

About University Of Kansas Medical Center

The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.

Locations

Westwood, Kansas, United States

Patients applied

0 patients applied

Trial Officials

Siddhartha Ganguly, MD

Principal Investigator

University of Kansas Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials